← Open Payments lookup

CLEMENT JOHN: Open Payments

NPI 1184271074 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,553 in 240 payments from 15 companies in 2025. Trend: 2023 $2,726 · 2024 $2,895 · 2025 $4,553

Food & beverage: $4,372Education: $181
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.49$1,076
Teva Pharmaceuticals USA, Inc.35$719
Vanda Pharmaceuticals Inc.21$449
Alkermes, Inc.21$404
Janssen Pharmaceuticals, Inc18$402
E.R. Squibb & Sons, L.L.C.17$354
ABBVIE INC.34$313
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$265
Neurocrine BioSciences, Inc.14$247
Supernus Pharmaceuticals, Inc.5$124

Products named: REXULTI, FANAPT, INVEGA SUSTENNA, ARISTADA, COBENFY, ABILIFY ASIMTUFII, AUSTEDO XR, VRAYLAR.

Industry payments across PA — which companies pay providers there.